Arno Therapeutics, Inc., a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company's product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of...
14 insider purchases on record · latest filing 2016-04-11.
Insiders have also filed 1 sale transaction at ARNI.